BCLP advises stereotaxis, Inc. on $12.5 million registered direct offering of common stock

International law firm BCLP advised Stereotaxis, Inc, a global leader in surgical robotics for minimally invasive endovascular intervention, on its $12.5 million registered direct offering of common stock.

Stereotaxis entered into a placement agency agreement with Lake Street Capital Markets, LLC, and a securities purchase agreement with certain investors, pursuant to which the company agreed to sell approximately $12.5 million in shares of common stock.

The initial closing under the Purchase Agreement occurred on July 18, 2025.

Stereotaxis intends to use proceeds from the offering to support working capital, accelerate product commercialization, fund research and development, and cover other general corporate purposes.

The deal team consisted of Rob Endicott (Securities, St. Louis) and Jennifer D’Alessandro (Securities, Denver) with assistance from Todd Kaye (Securities, St. Louis), Demmie Nicozisin (Corporate Transactions, St. Louis), and Julie Wagner (Tax, St. Louis).